Sana Biotechnology, Inc. (NASDAQ: SANA) reported Q4 EPS of ($0.21), $0.07 worse than the analyst estimate of ($0.14).

For earnings history and earnings-related data on Sana Biotechnology, Inc. (SANA) click here.